Physician profile
Antonio Mills
NPI 1073728705
$1,715.56
in general payments reported to CMS, 2019-2025
11 companies · $836 in 2025
The $836 reported for 2025 was more than what 87% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $344 · 2023: $330 · 2024: $205 · 2025: $836.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,371.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $338.47 | 2025 | Arista |
| Medtronic, INC. | $330.23 | 2023 | Cobalt Dr Mri Surescan, Venaseal |
| Coloplast Corp | $176.49 | 2024-2025 | |
| Neurocrine Biosciences, INC. | $127.50 | 2024 | Ingrezza |
| Bayer Healthcare Pharmaceuticals INC. | $123.67 | 2025 | |
| Intuitive Surgical, INC. | $123.58 | 2021 | |
| Jazz Pharmaceuticals INC. | $115.27 | 2021 | |
| Stryker Corporation | $104.97 | 2021 | |
| Madrigal Pharmaceuticals | $98.67 | 2025 | Rezdiffra |
| Amgen INC. | $90.51 | 2025 | Tezspire |
| Sumitomo Pharma America, INC. | $86.20 | 2025 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Mills listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.